TRUVADA ACCESS- emtricitabine and tenofovir disoproxil fumarate tablet, film coated 
Gilead Sciences, Inc

----------

Medication Guide
TRUVADA™ (tru-VAH-dah)
(emtricitabine and tenofovir disoproxil fumarate)
tablets

Read this Medication Guide before you start taking TRUVADA and each time you get a refill. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.

This Medication Guide provides information about two different ways that TRUVADA may be used. See the section "What is TRUVADA?" for important information about how TRUVADA may be used.

What is the most important information I should know about TRUVADA?

TRUVADA can cause serious side effects, including:

For more information about side effects, see the section "What are the possible side effects of TRUVADA?"

Other important information for people who take TRUVADA to help reduce their risk of getting HIV-1 infection:

Before taking TRUVADA to reduce your risk of getting HIV-1 infection:

While you are taking TRUVADA to reduce your risk of getting HIV-1:

What is TRUVADA?

TRUVADA is a prescription medicine that is used to:

TRUVADA works better to reduce the risk of getting HIV-1 when the medicines are in your bloodstream before you are exposed to HIV-1.

HIV is the virus that causes AIDS (Acquired Immune Deficiency Syndrome).

TRUVADA contains the medicines emtricitabine and tenofovir disoproxil fumarate.

It is not known if TRUVADA is safe and effective in children with HIV-1 infection who are under 12 years of age or who weigh less than 35 kg (77 pounds).

For people taking TRUVADA to reduce the risk of getting HIV-1 infection:

Do not take TRUVADA to help reduce your risk of getting HIV-1 if:

What should I tell my healthcare provider before taking TRUVADA?

Before taking TRUVADA, tell your healthcare provider about all of your medical conditions, including if you:

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Some medicines may interact with TRUVADA. Keep a list of your medicines and show it to your healthcare provider and pharmacist when you get a new medicine.

How should I take TRUVADA?

What are the possible side effects of TRUVADA?

TRUVADA may cause serious side effects, including:

The most common side effects of TRUVADA in people taking TRUVADA to treat HIV-1 infection include:

  • diarrhea
  • nausea
  • tiredness
  • headache
  • dizziness
  • depression
  • problems sleeping
  • abnormal dreams
  • rash

Common side effects in people who take TRUVADA to reduce the risk of getting HIV-1 infection include:

  • headache
  • stomach-area (abdomen) pain
  • decreased weight

These are not all the possible side effects of TRUVADA.

Call your doctor for medical advice about side effects.

To report SUSPECTED ADVERSE REACTIONS, contact Gilead Sciences, Inc. at safety_fc@gilead.com or the US FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.

How should I store TRUVADA?

Keep TRUVADA and all other medicines out of reach of children.

General information about TRUVADA.

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use TRUVADA for a condition for which it was not prescribed. Do not give TRUVADA to other people, even if they have the same symptoms you have. It may harm them.You can ask your healthcare provider or pharmacist for information about TRUVADA that is written for health professionals.

What are the ingredients in TRUVADA?

Active ingredients: emtricitabine and tenofovir disoproxil fumarate.

Inactive ingredients: Croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and pregelatinized starch (gluten free). The tablets are coated with Opadry II Light Blue Y-30-10671-A which contains FD&C Blue #2 aluminum lake, hydroxypropyl methylcellulose 2910, lactose monohydrate, titanium dioxide, and triacetin.

Manufactured for and distributed by:

Gilead Sciences, Inc.

Foster City, CA 94404

TRUVADA is a trademark of Gilead Sciences, Inc., or its related companies.

For more information go to www.TRUVADA.com.
© 2018 Gilead Sciences, Inc. All rights reserved.

21752-GS-032A

Revised May 2018

This Mediation Guide has been approved by the U.S Food and Drug Administration.

Revised: 9/2018
Gilead Sciences, Inc